Nephros (NEPH) Institutional Ownership $1.46 +0.01 (+0.69%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Nephros (NASDAQ:NEPH)CurrentInstitutional OwnershipPercentage41.10%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$70.89KNumber ofInstitutional Sellers(last 12 months)0 Get NEPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Nephros stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NEPH Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Nephros Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024Dimensional Fund Advisors LP17,631$37K0.0%N/A0.167% 4/26/2024Mesirow Financial Investment Management Inc.15,383$34K0.0%N/A0.146% 2/10/2023Bard Associates Inc.194,789$225K0.1%-22.7%1.887% 11/15/2022Elkhorn Partners Limited Partnership50,341$46K0.0%+48.1%0.488% 8/11/2022Bard Associates Inc.263,754$404K0.2%+7.0%2.556% 8/1/2022Cowen Prime Advisors LLC42,500$65K0.0%-47.1%0.412% Get the Latest News and Ratings for NEPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter. 5/23/2022Cantor Fitzgerald L. P.12,813$56K0.0%N/A0.124% 5/11/2022Bard Associates Inc.246,408$1.08M0.4%+6.0%2.388% 5/10/2022Elkhorn Partners Limited Partnership23,712$104K0.1%+56.0%0.230% 5/2/2022Cowen Prime Advisors LLC80,400$354K0.1%-87.3%0.780% 2/19/2022Wexford Capital LP3,650,529$646.53M27.0%N/A35.674% 2/14/2022Elkhorn Partners Limited Partnership15,200$90K0.1%+78.8%0.149% 2/8/2022Cowen Prime Advisors LLC633,050$3.74M1.3%-4.1%6.186% 2/8/2022Samjo Capital LLC425,000$2.51M1.7%-22.7%4.153% 11/9/2021BlackRock Inc.18,079$158K0.0%-23.0%0.177% 11/2/2021Cowen Prime Advisors LLC660,150$5.79M2.2%+5.4%6.461% 8/17/2021Wexford Capital LP3,631,197$36.85M5.6%+1.9%35.541% 8/13/2021Vanguard Group Inc.99,936$1.01M0.0%+3.9%0.978% 8/12/2021Bard Associates Inc.231,508$2.35M0.8%+5.5%2.266% 8/4/2021Cowen Prime Advisors LLC626,450$6.36M2.3%N/A6.290% 8/2/2021Advisor Group Holdings Inc.4,574$46K0.0%+91,380.0%0.046% 5/21/2021Citadel Advisors LLC18,421$123K0.0%N/A0.185% 5/18/2021Millennium Management LLC18,909$126K0.0%-10.4%0.190% 5/18/2021Citadel Advisors LLC18,421$123K0.0%N/A0.185% 5/13/2021Wexford Capital LP3,564,530$23.70M3.5%+0.1%35.781% 5/7/2021BlackRock Inc.23,559$157K0.0%+20.9%0.237% 4/27/2021Cowen Prime Services LLC622,750$4.14M1.6%+8.3%6.258% 2/12/2021Elkhorn Partners Limited Partnership14,290$123K0.1%-9.0%0.145% 2/11/2021Samjo Capital LLC550,000$4.72M4.0%N/A5.575% 2/10/2021HighTower Advisors LLC55,710$478K0.0%+28.9%0.565% 1/27/2021Cowen Prime Services LLC575,077$4.93M2.2%+86.1%5.829% 11/6/2020BlackRock Inc.18,333$132K0.0%-28.1%0.203% (Data available from 1/1/2016 forward) NEPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NEPH shares? During the previous two years, the following institutional investors and hedge funds held shares of Nephros shares: Bard Associates Inc. ($225K), Elkhorn Partners Limited Partnership ($46K), and Dimensional Fund Advisors LP ($37K), Mesirow Financial Investment Management Inc. ($34K).Learn more on NEPH's institutional investors. What percentage of Nephros stock is owned by institutional investors? 41.10% of Nephros stock is owned by institutional investors. Learn more on NEPH's institutional investor holdings. Which institutional investors have been buying Nephros stock? The following institutional investors have purchased Nephros stock in the last 24 months: Dimensional Fund Advisors LP ($17.63K), Elkhorn Partners Limited Partnership ($16.34K), and Mesirow Financial Investment Management Inc. ($15.38K). How much institutional buying is happening at Nephros? Institutional investors have bought a total of 49,355 shares in the last 24 months. This purchase volume represents approximately $85.76K in transactions. Which Nephros major shareholders have been selling company stock? The following institutional investors have sold Nephros stock in the last 24 months: Bard Associates Inc. ($57.34K). How much institutional selling is happening at Nephros? Institutional investors have sold a total of 57,335 shares in the last 24 months. This volume of shares sold represents approximately $66.35K in transactions. Related Companies Cytosorbents Institutional Ownership Lucid Diagnostics Institutional Ownership iCAD Institutional Ownership Envoy Medical Institutional Ownership Allurion Technologies Institutional Ownership CollPlant Biotechnologies Institutional Ownership Apyx Medical Institutional Ownership Co-Diagnostics Institutional Ownership SurgePays Institutional Ownership Femasys Institutional Ownership This page (NASDAQ:NEPH) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nephros, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nephros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
